We have licensed vaccines for both anthrax and smallpox. In addition, we have licensed antitoxin to treat victims of Botulinum poisoning. Since 9/11 and the anthrax attacks of late 2001, CBER has worked with numerous manufacturers to develop and bring to licensure countermeasures against many potential biological agents. There are products in development that include new vaccines against anthrax, smallpox, botulism, plague, tularemia, Ebola, and others, as well as new therapeutics to treat disease caused by these agents and others. | 
